NASDAQ Companies

Nashville, TN, Oct. 02, 2024 (GLOBE NEWSWIRE) — American Rebel Holdings, Inc. (NASDAQ: AREB) (“American Rebel” or the “Company”), the […]

For quarter ended Sept. 30, 2024, Company expects to report approximately $4.5 million in revenue compared to $65,235.00 reported in […]

MIAMI, Oct. 02, 2024 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular […]

TORONTO, Ontario, Oct. 02, 2024 (GLOBE NEWSWIRE) — ZenaTech, Inc. (Nasdaq: ZENA) (“ZenaTech”), a technology company specializing in AI (Artificial […]

Name change to “Climb Bio” marks the Company’s transition and focus on developing treatments for immune-mediated diseases Climb Bio will […]

ATLANTA, Ga., Oct. 02, 2024 (GLOBE NEWSWIRE) — GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company specializing in developing human […]

SUNNYVALE, Calif., Oct. 02, 2024 (GLOBE NEWSWIRE) — News SummaryFortinet® (NASDAQ: FTNT), the global cybersecurity leader driving the convergence of […]

HESPERIA, Calif., Oct. 02, 2024 (GLOBE NEWSWIRE) — 5E Advanced Materials, Inc. (Nasdaq: FEAM) (ASX: 5EA) (“5E” or the “Company”), […]

ENCINO, Calif., Oct. 02, 2024 (GLOBE NEWSWIRE) — NETSOL Technologies, Inc. (Nasdaq: NTWK), a global leader in delivering state-of-the-art solutions for the […]

– ATH434 shows promise as a disease-modifying therapy for MSA – – ATH434-202 Phase 2 interim data demonstrate stabilization of […]